.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Depression represents a leading cause of global disability, yet access to evidence-based treatments like Cognitive Behavioral Therapy (CBT) remains limited. Consequently, researchers are exploring scalable, low-cost interventions. Cognitive Bias Modification for Interpretation (CBM-I) serves as a promising approach grounded in cognitive theory. Therefore, the CURED (Cognitive bias modification Utilised to Rectify Errors for Depression) trial aims to evaluate the feasibility of a novel delivery method.
The CURED study is a double-blind, parallel-group feasibility randomised controlled trial. Specifically, the team recruited 60 adults with clinical depression. These participants were randomly assigned to either the CURED intervention or a neutral control. Both groups received six weekly sessions via mailed pen-and-paper booklets. Furthermore, remote researcher support ensured fidelity throughout the treatment period. This approach notably addresses the digital divide by offering a non-computerized therapeutic option. Consequently, it may improve access for populations with limited internet connectivity.
The primary objectives focus on determining whether this intervention is safe and acceptable for patients. Researchers will assess feasibility metrics like recruitment, retention, and adherence rates. In addition, the study evaluates the integrity of blinding and safety through monitoring adverse events. Secondary outcomes include changes in depressive symptoms, anxiety, and psychosocial functioning. If this feasibility trial succeeds, it will provide the foundation for a definitive efficacy trial. Moreover, it highlights the potential for task-shifting in mental health care by using structured self-help tools.
CBM-I is a psychological intervention designed to change the way individuals interpret ambiguous information. It aims to shift negative interpretation biases toward more benign or positive ones, which can help alleviate symptoms of depression and anxiety.
CURED utilizes a pen-and-paper booklet format co-developed with individuals with lived experience. This contrasts with traditional CBM-I, which often relies on computerized tasks, making CURED more accessible in resource-limited settings.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Karamanlı KA et al. Cognitive bias modification Utilised to Rectify Errors for Depression (CURED): a double-blind, parallel-group feasibility randomised controlled trial in adults with depression. Trials. 2026 Apr 06. doi: 10.1186/s13063-026-09668-6. PMID: 41943158.
Blackwell SE, et al. (2015). Optimising positive cognitive bias modification as a treatment for depression: Considerations and challenges. Psychological Medicine, 45(10), 2087-2108.
World Health Organization. (2023). Depression: Key facts. Available at: https://www.who.int/news-room/fact-sheets/detail/depression
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A feasibility study evaluating the CURED intervention, a low-cost pen-and-paper cognitive bias modification tool for clinical depression....
5 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
